Abstract
Vitamin D has garnered much research and debate about supplementation in recent years, not only as it pertains to patients with kidney disease but also to those in the general population. This review discusses observational and available clinical trial evidence about the effects of both calcitriol and vitamin D analogs (active) and ergocalciferol and cholecalciferol (nutritional) vitamin D in patients with CKD and ESRD.
Publication types
-
Research Support, N.I.H., Extramural
-
Review
MeSH terms
-
Chronic Disease
-
Dietary Supplements* / adverse effects
-
Evidence-Based Medicine
-
Humans
-
Kidney Diseases / blood
-
Kidney Diseases / complications
-
Kidney Diseases / therapy*
-
Kidney Failure, Chronic / blood
-
Kidney Failure, Chronic / complications
-
Kidney Failure, Chronic / therapy*
-
Treatment Outcome
-
Vitamin D / adverse effects
-
Vitamin D / analogs & derivatives
-
Vitamin D / blood
-
Vitamin D / therapeutic use*
-
Vitamin D Deficiency / blood
-
Vitamin D Deficiency / complications
-
Vitamin D Deficiency / drug therapy*